Trials / Completed
CompletedNCT02394392
Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)
Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient: a Prospective, Cross-sectional and Open-label 8 Week Switching Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12,691 (actual)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
1. Investigate the clinical characteristics, medication satisfaction and quality of life of anti-hypertensive drugs in Korean hypertensive patients 2. Observe the changes of medication satisfaction and compliance in patients after switchting to Fimasartan
Conditions
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-08-01
- Completion
- 2015-10-01
- First posted
- 2015-03-20
- Last updated
- 2016-07-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02394392. Inclusion in this directory is not an endorsement.